1 / 3
google
Article details
- Package size
- 60
- Selling units
- 60
- Measure
- g
- Galenic form
- Salbe
- Galenic group
- Salben
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Pierre Fabre Pharma SA
4052 Basel
Authorization information
- Swissmedic authorization number
- 67963
- Drug name
- Takrozem 1mg/g, Salbe
- Galenic form
- SALB
- ATC Code
- D11AH01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 16/12/2021
- Authorization expiration date
- 15/12/2026
- IT Number
- 10.04.0.
- Domain
- Human medicine
Package details
- Description (FR)
- TAKROZEM ong 1 mg/g tb 60 g
- Description (DE)
- TAKROZEM Salbe 1 mg/g Tb 60 g
- Market launch
- 16/12/2021
- Narcotic (BTM)
- No